C9 and paroxysmal nocturnal hemoglobinuria: Since membrane attack complex C5b-C9 (MAC) is responsible for erythrocyte lysis in PNH patients, this also explains the effectiveness of CC inhibitors, such as eculizumab 9 or compstatin, in treatment of this disorder 25.